Metastatic Wilms' tumor in young adult: case report

Authors

  • Josué Vázquez Arizmendi Instituto Estatal de Cancerología “Dr. Arturo Beltrán Ortega”, Guerrero, Acapulco, México. https://orcid.org/0000-0002-3310-9075
  • Santos Olivares Pineda Instituto Estatal de Cancerología “Dr. Arturo Beltrán Ortega”, Guerrero, Acapulco, México. https://orcid.org/0009-0004-5617-5915
  • Iván Meneses Morales Universidad Juárez del Estado de Durango, Durango, Mexico. https://orcid.org/0000-0002-3146-1374
  • Carlos Enrique Arciniega Vega Instituto Estatal de Cancerología “Dr. Arturo Beltrán Ortega”, Guerrero, Acapulco, México. https://orcid.org/0009-0009-6209-2987
  • Gabriel Ernesto Díaz Juárez Instituto Estatal de Cancerología “Dr. Arturo Beltrán Ortega”, Guerrero, Acapulco, México.
  • Martín Morrrugares Ixtepan Instituto Estatal de Cancerología “Dr. Arturo Beltrán Ortega”, Guerrero, Acapulco, México. https://orcid.org/0009-0008-8048-9745
  • Azucena Ocampo Bárcenas Instituto Estatal de Cancerología “Dr. Arturo Beltrán Ortega”, Guerrero, Acapulco, México.

DOI:

https://doi.org/10.48193/069ehc32

Keywords:

: tumor de wilms, nefroblastoma

Abstract

Clinical case: a 20-year-old male patient with type 1 obesity presents with abdominal and dorsal pain. Pathological diagnosis reported Wilms tumor (WT) stage IV. He received preoperative chemotherapy and subsequently underwent left radical nephrectomy. Currently, the patient remains asymptomatic and without evidence of recurrence 12 months after surgery.

Relevance: Wilms tumor or nephroblastoma is an uncommon pathology in the adult population with very few reported cases. The advanced stage of the disease complicates surgical and oncologic treatment. 

Medical implications: currently, there are no defined guidelines for the treatment of WT in the adult population due to its low frequency and the lack of information on the strategies employed in high-specialty hospitals where these cases have been managed.

Conclusions: the therapeutic approach of WT in adults presents significant challenges, making it necessary to establish a standardized model of care and management. The partial response to chemotherapy and the appearance of new lesions indicates the possibility of requiring additional treatments, as well as strict surveillance. Systematic recording and analysis of these cases will contribute to the development of more effective therapeutic strategies for this rare clinical entity.

References

Mitry E, Ciccolallo L, Coleman MP, Gatta G, Pritchard-Jones K, EUROCARE Working Group. Incidence of and survival from Wilms’ tumour in adults in Europe: data from the EUROCARE study. European Journal of Cancer (Oxford, England: 1990). 2006;42(14): 2363–2368. https://doi.org/10.1016/j.ejca.2006.04.009.

Tripathi S, Mishra A, Popat VC, Husain SA. Wilms’ Tumor in Adults—Conventional and Unconventional Presentations of a Rare Entity with a Review of Literature. Journal of Kidney Cancer and VHL. 2021;8(2): 40–48. https://doi.org/10.15586/jkcvhl.v8i2.186.

Zhao Q, Xiong Q, Song Q. Metastatic adult Wilms’ tumor managed by chemotherapy, immunotherapy and target therapy: a case report. Future Science OA. 10(1): FSO915. https://doi.org/10.2144/fsoa-2023-0156.

Mounnarath ET, Zwieky W, Aedo-Lopez V, Fazli O, Sheridan BJ. Adult Wilms tumour: A case report. SAGE Open Medical Case Reports. 2022;10: 2050313X221097265. https://doi.org/10.1177/2050313X221097265.

Huszno J, Starzyczny–Słota D, Jaworska M, Nowara E. Adult Wilms’ tumor – diagnosis and current therapy. Central European Journal of Urology. 2013;66(1): 39–44. https://doi.org/10.5173/ceju.2013.01.art12.

Pérez-García J, Machado I, Calabuig-Fariñas S, Navarro S, Llombart-Bosch A, Pérez-García J, et al. Tumor de Wilms con diferenciación muscular. Histología, inmunofenotipo y análisis molecular de tres casos. Revista Espanola de Patologia. 2012;45(2): 67–75. https://doi.org/10.1016/J.PATOL.2011.11.007.

Apple A, Lovvorn HN. Wilms Tumor in Sub-Saharan Africa: Molecular and Social Determinants of a Global Pediatric Health Disparity. Frontiers in Oncology. 2020;10: 606380. https://doi.org/10.3389/fonc.2020.606380.

Reinhard H, Aliani S, Ruebe C, Stöckle M, Leuschner I, Graf N. Wilms’ Tumor in Adults: Results of the Society of Pediatric Oncology (SIOP) 93-01/Society for Pediatric Oncology and Hematology (GPOH) Study. Journal of Clinical Oncology. 2004;22(22): 4500–4506. https://doi.org/10.1200/JCO.2004.12.099.

Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001-10: a population-based registry study. The Lancet. Oncology. 2017;18(6): 719–731. https://doi.org/10.1016/S1470-2045(17)30186-9.

Zhang JJ, Yang LF, Zhang YZ, Xie XH. Clinical value of ultrasound in adult Wilms’ tumor patient with uremia: A case report and literature review. Medicine. 2023;102(49): e36381. https://doi.org/10.1097/MD.0000000000036381.

Saltzman AF, Carrasco A, Amini A, Cost NG. Patterns of Care and Survival Comparison of Adult and Pediatric Wilms Tumor in the United States: A Study of the National Cancer Database. Urology. 2020;135: 50–56. https://doi.org/10.1016/j.urology.2019.10.007.

Hermi A, Mrad Dali K, Hadj Alouane H, Chelly B, Ben Rejeb N, Nouira Y. Adult’s Wilms tumor: A case report. Urology Case Reports. 2022;44: 102171. https://doi.org/10.1016/j.eucr.2022.102171.

Modi S, Tiang KW, Inglis P, Collins S. Adult Wilms’ Tumour: Case Report and Review of Literature. Journal of Kidney Cancer and VHL. 2016;3(2): 1–7. https://doi.org/10.15586/jkcvhl.2016.52.

Huang JL, Liao Y, An Y, Qiu MX. Spontaneous rupture of adult Wilms’ tumor: A case report and review of the literature. Canadian Urological Association Journal = Journal De l’Association Des Urologues Du Canada. 2015;9(7–8): E531-534. https://doi.org/10.5489/cuaj.2539.

Re GG, Hazen-Martin DJ, Sens DA, Garvin AJ. Nephroblastoma (Wilms’ tumor): a model system of aberrant renal development. Seminars in Diagnostic Pathology. 1994;11(2): 126–135.

Riccardi VM, Sujansky E, Smith AC, Francke U. Chromosomal imbalance in the Aniridia-Wilms’ tumor association: 11p interstitial deletion. Pediatrics. 1978;61(4): 604–610.

Martin-Dorantes M A, Rochel-Pérez E A, Chi-Méndez C G, Bastarrachea-Solis M A, Flores-Tapia J P, Méndez-Domínguez N. “No he escuchado que ´nadien´ conocido haya muerto por eso”: Percepciones sobre la prevención del cáncer de próstata en un grupo de hombres de Yucatán. Revista Mexicana de Urología. 2024;84(5): 1–14.

Gratias EJ, Dome JS, Jennings LJ, Chi YY, Tian J, Anderson J, et al. Association of Chromosome 1q Gain With Inferior Survival in Favorable-Histology Wilms Tumor: A Report From the Children’s Oncology Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2016;34(26): 3189–3194. https://doi.org/10.1200/JCO.2015.66.1140.

Lopes RI, Lorenzo A. Recent advances in the management of Wilms’ tumor. F1000Research. 2017;6: 670. https://doi.org/10.12688/f1000research.10760.1.

Dénes FT, Duarte RJ, Cristófani LM, Lopes RI. Pediatric Genitourinary Oncology. Frontiers in Pediatrics. 2013;1: 48. https://doi.org/10.3389/fped.2013.00048.

Kieran K, Ehrlich PF. Current surgical standards of care in Wilms tumor. Urologic Oncology. 2016;34(1): 13–23. https://doi.org/10.1016/j.urolonc.2015.05.029.

Brok J, Treger TD, Gooskens SL, van den Heuvel-Eibrink MM, Pritchard-Jones K. Biology and treatment of renal tumours in childhood. European Journal of Cancer (Oxford, England: 1990). 2016;68: 179–195. https://doi.org/10.1016/j.ejca.2016.09.005.

Dome JS, Graf N, Geller JI, Fernandez CV, Mullen EA, Spreafico F, et al. Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology. 2015;33(27): 2999–3007. https://doi.org/10.1200/JCO.2015.62.1888.

Downloads

Published

2025-06-03

Issue

Section

Clinical cases